Could a bone drug stop brain damage in rare Fahr's disease?
NCT ID NCT05662111
First seen Mar 09, 2026 · Last updated May 22, 2026 · Updated 9 times
Summary
This study tests whether etidronate, a drug used for bone disorders, can slow or stop calcium buildup in the brain that causes Fahr's disease. The trial will enroll 98 adults with Fahr's disease or syndrome. Participants will receive either etidronate or a placebo for a year to see if the drug improves thinking, movement, and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FAHR DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University College London Hospital
NOT_YET_RECRUITINGLondon, United Kingdom
Contact
Contact Phone: •••-•••-••••
-
University Medical Center Utrecht
RECRUITINGUtrecht, Utrecht, 3584 CX, Netherlands
Contact
Conditions
Explore the condition pages connected to this study.